FHL1 as a tumor repressor gene is authenticated to be poorly expressed in varying cancers, containing liver cancer [19], oral cancer [20], head and neck squamous cell carcinoma [21], and breast cancer [22]. The gene discussed is FHL1; the disease is liver cancer.